Review

Published on 23 Nov 2021

Progress in the Application of Immune Checkpoint Inhibitor-Based Immunotherapy for Targeting Different Types of Colorectal Cancer

in Cancer Immunity and Immunotherapy

Rui He
Yefang Lao
Wenyan Yu
Xiaohui Zhang
Min Jiang
Chunrong Zhu

Frontiers in Oncology

doi 10.3389/fonc.2021.764618

6,277 views
22 citations

Case Report

Published on 23 Nov 2021

Anti-PD-1 Immunotherapy Combined With Stereotactic Body Radiation Therapy and GM-CSF as Salvage Therapy in a PD-L1-Positive Patient With Refractory Metastatic Thyroid Hürthle Cell Carcinoma: A Case Report and Literature Review

in Cancer Immunity and Immunotherapy

Haihua He
Tangpeng Xu
Ping Li
Guohua Jia
Xiangpan Li
Qibin Song

Frontiers in Oncology

doi 10.3389/fonc.2021.782646

3,111 views
6 citations

Original Research

Published on 23 Nov 2021

Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation

in Cancer Immunity and Immunotherapy

Tian Tian
Min Yu
Juan Li
Maoqiong Jiang
Daiyuan Ma
Shubin Tang
Zhiyu Lin
Lin Chen
Youling Gong
Jiang Zhu

Frontiers in Oncology

doi 10.3389/fonc.2021.739090

5,048 views
26 citations

Case Report

Published on 19 Nov 2021

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report

in Cancer Immunity and Immunotherapy

Tian Zeng
Lei Zhang
Can Chen
Xiang Zhao
Xiaoqing Liu
Fengwei Ran
Tingting Yong
Ying Yang
Henghui Zhang
Yanling Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.767957

2,577 views
4 citations

Original Research

Published on 19 Nov 2021

Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer

in Cancer Immunity and Immunotherapy

Yang Gao
Zhao Sun
Junjie Gu
Zhe Li
Xiuxiu Xu
Chunling Xue
Xuechun Li
Lin Zhao
Jianfeng Zhou
Chunmei Bai

Frontiers in Oncology

doi 10.3389/fonc.2021.748465

4,039 views
15 citations

Review

Published on 19 Nov 2021

Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor

in Cancer Immunity and Immunotherapy

Madelyn Espinosa-Cotton
Nai-Kong V. Cheung

Frontiers in Oncology

doi 10.3389/fonc.2021.772862

7,049 views
10 citations

Review

Published on 19 Nov 2021

Cancer-Immunity Cycle and Therapeutic Interventions- Opportunities for Including Pet Dogs With Cancer

in Cancer Immunity and Immunotherapy

Samantha K. Von Rueden
Timothy M. Fan

Frontiers in Oncology

doi 10.3389/fonc.2021.773420

5,667 views
13 citations

Review

Published on 18 Nov 2021

Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research

in Cancer Immunity and Immunotherapy

Morgane M. Cogels
Redouane Rouas
Ghanem E. Ghanem
Philippe Martinive
Ahmad Awada
Dirk Van Gestel
Mohammad Krayem

Frontiers in Oncology

doi 10.3389/fonc.2021.784947

17,028 views
61 citations

Review

Published on 17 Nov 2021

Current Strategies for Tumor Photodynamic Therapy Combined With Immunotherapy

in Cancer Immunity and Immunotherapy

Jianfeng Hua
Pan Wu
Lu Gan
Zhikun Zhang
Jian He
Liping Zhong
Yongxiang Zhao
Yong Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.738323

9,270 views
34 citations

Review

Published on 17 Nov 2021

Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges

in Cancer Immunity and Immunotherapy

Zhitao Li
Guoqiang Sun
Guangshun Sun
Ye Cheng
Liangliang Wu
Qian Wang
Chengyu Lv
Yichan Zhou
Yongxiang Xia
Weiwei Tang

Frontiers in Oncology

doi 10.3389/fonc.2021.771335

6,598 views
26 citations

Systematic Review

Published on 11 Nov 2021

Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Xiuqiong Chen
Fanqiao Meng
Richeng Jiang

Frontiers in Oncology

doi 10.3389/fonc.2021.746976

4,570 views
40 citations

Case Report

Published on 11 Nov 2021

Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature

in Cancer Immunity and Immunotherapy

Juri Alessandro Giannotta
Bruno Fattizzo
Wilma Barcellini

Frontiers in Oncology

doi 10.3389/fonc.2021.756589

3,977 views
3 citations

Original Research

Published on 10 Nov 2021

Disulfiram Improves the Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Expression via Epigenetically Reactivation of IRF7 in Triple Negative Breast Cancer

in Cancer Immunity and Immunotherapy

Xin Zheng
Zijian Liu
Mi Mi
Qiuyue Wen
Gang Wu
Liling Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.734853

5,841 views
19 citations

Original Research

Published on 05 Nov 2021

Immunogenomic Landscape and Immune-Related Gene-Based Prognostic Signature in Asian Gastric Cancer

in Cancer Immunity and Immunotherapy

Chenchen Mao
Liangliang Ma
Yingpeng Huang
Xinxin Yang
He Huang
Wentao Cai
Andriamifehimanjaka Sitrakiniaina
Ruihong Gu
Xiangyang Xue
Xian Shen

Frontiers in Oncology

doi 10.3389/fonc.2021.750768

3,483 views
8 citations

Original Research

Published on 05 Nov 2021

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets

in Cancer Immunity and Immunotherapy

Yinqi Zhang
Chengqi Gao
Fei Cao
Ying Wu
Shuanggang Chen
Xue Han
Jingqin Mo
Zhiyu Qiu
Weijun Fan
Penghui Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.755341

7,797 views
18 citations

Clinical Trial

Published on 05 Nov 2021

A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study

in Cancer Immunity and Immunotherapy

An-Wen Xiong
Jue-Min Fang
Sheng-Xiang Ren
Wei Li
Jing Wang
Yu Zhao
Guo-You Chen
Qing Xu
Cai-Cun Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.745699

3,909 views
7 citations

Navigation group

Articles

Progress in the Application of Immune Checkpoint Inhibitor-Based Immunotherapy for Targeting Different Types of Colorectal Cancer

Anti-PD-1 Immunotherapy Combined With Stereotactic Body Radiation Therapy and GM-CSF as Salvage Therapy in a PD-L1-Positive Patient With Refractory Metastatic Thyroid Hürthle Cell Carcinoma: A Case Report and Literature Review

Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report

Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer

Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor

Cancer-Immunity Cycle and Therapeutic Interventions- Opportunities for Including Pet Dogs With Cancer

Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research

Current Strategies for Tumor Photodynamic Therapy Combined With Immunotherapy

Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges

Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature

Disulfiram Improves the Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Expression via Epigenetically Reactivation of IRF7 in Triple Negative Breast Cancer

Immunogenomic Landscape and Immune-Related Gene-Based Prognostic Signature in Asian Gastric Cancer

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets

A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study